Efficacy of Free Versus Low Residue Diet as Preparation for Screening Colonoscopy (CriLi)
Primary Purpose
Colorectal Cancer, Colon Polyp, Colon Adenoma
Status
Terminated
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Free diet
Three days low residue diet
Sponsored by
About this trial
This is an interventional diagnostic trial for Colorectal Cancer focused on measuring colonoscopy, bowel cleansing, low fiber diet, colonoscopy preparation
Eligibility Criteria
Inclusion Criteria:
- Men and women between 50 and 69 years old.
- Participants in the Program for the Early Detection of Colorectal Cancer with a positive result in the test for detecting occult blood in feces
- That they accept a colonoscopy and that they agree to participate in the study.
Exclusion Criteria:
- Contraindication to performing a colonoscopy.
- Severe renal insufficiency (<30 ml / min).
- Known hypersensitivity or allergy to polyethylene glycol, ascorbic acid or sulfate.
- Known glucose-6-phosphate dehydrogenase deficiency.
- Known phenylketonuria.
- Known dyselectrolytemia: hyper / hyponatremia, hyperphosphatemia, hypermagnesemia, hyper / hypokalemia, hypocalcemia.
- Gastric emptying disorders: Known gastroparesis.
- Known hypoalbuminemia less than 3.4 g / dl.
- Crohn's disease or known ulcerative colitis.
- Participants with difficult-to-control hypertension (SBP> 170mmHg or TAD> 100mmHg) or NYHA grade III or IV heart failure.
- Ascites of any etiology
- People with cognitive impairment or mental illness that makes it difficult to adhere to instructions.
- People who do not understand Catalan or Spanish.
- Factors of poor preparation: liver cirrhosis, diabetes mellitus, treatment with tricyclic antidepressants, opioids or neuroleptics, limited mobility, chronic constipation, history of colon or intestinal resection (appendectomy is not an exclusion criterion), poor preparation in previous colonoscopy Parkinson's disease, multiple sclerosis.
Sites / Locations
- Hospital Universitari Parc Taulí
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
3 days of low residue diet
Free diet
Arm Description
Currently participants in the colorectal cancer screening program follow a 3 days low residue diet before colonoscopy. This is the active comparator arm of this study.
Participants assigned to this arm are NOT instructed to follow any kind of restriction in the diet before colonoscopy.
Outcomes
Primary Outcome Measures
Adequate bowel cleansing
Bowel cleansing has a rating using the Boston Bowel Preparation Scale above 1 in each segment . This score ranges fron 0 to 3 in each one of the three segments. Zero is the worst outcome and 3 is the best cleansing
Secondary Outcome Measures
Diet tolerability
Tolerance to the diet assigned to the participant measured with a likert scale from 0 to 5, 0 the worst ad 5 the best.
Preparation tolerability
Tolerance to the cleansing solution used for bowel cleansing measured with a likert scale from 0 to 5, 0 the worst ad 5 the best.
Adenoma detection
An adenoma was detected, resected and confirmed by the histology report in the colonoscopy.
Polyp detection
Polyp detection in the colonoscopy as reported by the endoscopist.
Ceacal intubation time
Time expended in reaching the cecum
Withdrawal time
Time expended in the withdrawal from cecum till the anus.
Excellent cleansing
Colonoscopy achieving a Boston Bowel Preparation Scale (BBPS) of at least 8 points or above. BBPS global score ranges from 0 to 9, being 9 the best cleansing outcome.
Information perceived quality
Perceived quality of the instructions and education received for the colonoscopy. preparation by the participant. Assessed using a likert scale from 0 to 5. Five is the best outcome and 0 the worst.
Preparation quality in each segment
Boston Bowel Preparation Score in each segment, it ranges from 0 to 3 being 3 the best cleansing outcome and 0 the worst.
Full Information
NCT ID
NCT04664543
First Posted
December 6, 2020
Last Updated
January 23, 2021
Sponsor
Parc Taulí Hospital Universitari
Collaborators
Consorci Sanitari de Terrassa, Hospital Mutua de Terrassa
1. Study Identification
Unique Protocol Identification Number
NCT04664543
Brief Title
Efficacy of Free Versus Low Residue Diet as Preparation for Screening Colonoscopy
Acronym
CriLi
Official Title
Efficacy of Free Versus Low Residue Diet as Preparation for Screening Colonoscopy: CriLi Study, a Pilot Trial
Study Type
Interventional
2. Study Status
Record Verification Date
January 2021
Overall Recruitment Status
Terminated
Why Stopped
Organization and logistic problems due to COVID19 pandemy
Study Start Date
December 1, 2019 (Actual)
Primary Completion Date
December 30, 2020 (Actual)
Study Completion Date
December 30, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Parc Taulí Hospital Universitari
Collaborators
Consorci Sanitari de Terrassa, Hospital Mutua de Terrassa
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
One tricky aspect of the recommendations for colonoscopy prep is diet. This has a significant impact on the experience of the patient or participant in the screening program and, on the other hand, low adherence has been found in some studies despite a potential Hawthorne effect . It is noteworthy that despite its impact on patient experience, it is an area for which little evidence is available, which is why the guidelines give low-quality recommendations and there is probably considerable variability in clinical practice .
In the early days of colonoscopy, a liquid diet for 48 hours was mainly recommended, although some centers indicated a low-residue diet or even the commercially available NASA astronaut diet. Later, the indication for a liquid diet was consolidated until finally numerous studies were published in favor of a low-residue diet, managing to increase tolerance and the quality of the preparation . A limitation of the preparation studies must be borne in mind that the colon cleansing rating scales were not introduced until 1999 when the Aronchick scale was published.
Although there is solid evidence in favor of a low-residue diet versus a liquid diet, the investigators do not have evidence on how many days of a low-residue diet should be recommended, and this is reflected in the ESGE (European Society of Gastrointestinal Endoscopy) and ASGE (American Society of Gastrointestinal Endoscopy) guidelines . A randomized clinical trial comparing 3 days versus 1 day of a low residue diet has recently been published . There were no statistically significant differences in the rate of adequate preparations (82.7% vs. 85.6% OR 1.2 95% IC 0.72 to 2.15). However, this study has limited statistical power and a design that allows a non-inferiority analysis has not been followed. In relation to this, our research group is finalizing a non-inferiority clinical trial in whose intermediate analysis, with 421 participants, the non-inferiority of 1 day of diet is fulfilled (rate of poor preparation in 1 day 0.95% vs. 4.74% in 3 days; d + 5%, difference -3.78% IC -6.88% to -1.12%) (38).
It is likely, taking into account the available evidence and its evolution, that diet plays a secondary role in preparation. Although no studies designed to directly assess this have been conducted, the research group has indirect data.
Walter et al, under the hypothesis that the impact of the fractional preparation and the new preparations on the preparation diminished the importance of the diet, conducted a non-inferiority clinical trial between 2012 and 2013 in which they randomized the patients to follow a diet liquid versus low residue for one day and fractional preparation with Moviprep (39). They established a non-inferiority margin of -13.5%. Their results show a rate of good preparation (Boston> 5) in 68/72 (94.4%) in a liquid diet compared to 60/68 (88.2%) in a low-residue diet (p = 0.04) with a difference of -5.08% demonstrating non-inferiority of the low residue diet.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Cancer, Colon Polyp, Colon Adenoma
Keywords
colonoscopy, bowel cleansing, low fiber diet, colonoscopy preparation
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
100 (Actual)
8. Arms, Groups, and Interventions
Arm Title
3 days of low residue diet
Arm Type
Active Comparator
Arm Description
Currently participants in the colorectal cancer screening program follow a 3 days low residue diet before colonoscopy. This is the active comparator arm of this study.
Arm Title
Free diet
Arm Type
Experimental
Arm Description
Participants assigned to this arm are NOT instructed to follow any kind of restriction in the diet before colonoscopy.
Intervention Type
Other
Intervention Name(s)
Free diet
Other Intervention Name(s)
Liberal diet, habitual diet
Intervention Description
To follow the regular dietary habits with no restriction nor modification.
Intervention Type
Other
Intervention Name(s)
Three days low residue diet
Other Intervention Name(s)
low fiber diet
Intervention Description
To follow the three days before colonoscopy a diet with low content in fiber or residues.
Primary Outcome Measure Information:
Title
Adequate bowel cleansing
Description
Bowel cleansing has a rating using the Boston Bowel Preparation Scale above 1 in each segment . This score ranges fron 0 to 3 in each one of the three segments. Zero is the worst outcome and 3 is the best cleansing
Time Frame
During colonoscopy (At the withdrawal phase)
Secondary Outcome Measure Information:
Title
Diet tolerability
Description
Tolerance to the diet assigned to the participant measured with a likert scale from 0 to 5, 0 the worst ad 5 the best.
Time Frame
The day of the colonoscopy just before beginning
Title
Preparation tolerability
Description
Tolerance to the cleansing solution used for bowel cleansing measured with a likert scale from 0 to 5, 0 the worst ad 5 the best.
Time Frame
The day of the colonoscopy just before beginning
Title
Adenoma detection
Description
An adenoma was detected, resected and confirmed by the histology report in the colonoscopy.
Time Frame
adenoma detection is done during the colonoscopy but assesment will be done at the end of the study with the histology reports
Title
Polyp detection
Description
Polyp detection in the colonoscopy as reported by the endoscopist.
Time Frame
During colonoscopy
Title
Ceacal intubation time
Description
Time expended in reaching the cecum
Time Frame
During colonoscopy
Title
Withdrawal time
Description
Time expended in the withdrawal from cecum till the anus.
Time Frame
During colonoscopy
Title
Excellent cleansing
Description
Colonoscopy achieving a Boston Bowel Preparation Scale (BBPS) of at least 8 points or above. BBPS global score ranges from 0 to 9, being 9 the best cleansing outcome.
Time Frame
During colonoscopy
Title
Information perceived quality
Description
Perceived quality of the instructions and education received for the colonoscopy. preparation by the participant. Assessed using a likert scale from 0 to 5. Five is the best outcome and 0 the worst.
Time Frame
The day of the colonoscopy just before beginning
Title
Preparation quality in each segment
Description
Boston Bowel Preparation Score in each segment, it ranges from 0 to 3 being 3 the best cleansing outcome and 0 the worst.
Time Frame
During colonoopy
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
69 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Men and women between 50 and 69 years old.
Participants in the Program for the Early Detection of Colorectal Cancer with a positive result in the test for detecting occult blood in feces
That they accept a colonoscopy and that they agree to participate in the study.
Exclusion Criteria:
Contraindication to performing a colonoscopy.
Severe renal insufficiency (<30 ml / min).
Known hypersensitivity or allergy to polyethylene glycol, ascorbic acid or sulfate.
Known glucose-6-phosphate dehydrogenase deficiency.
Known phenylketonuria.
Known dyselectrolytemia: hyper / hyponatremia, hyperphosphatemia, hypermagnesemia, hyper / hypokalemia, hypocalcemia.
Gastric emptying disorders: Known gastroparesis.
Known hypoalbuminemia less than 3.4 g / dl.
Crohn's disease or known ulcerative colitis.
Participants with difficult-to-control hypertension (SBP> 170mmHg or TAD> 100mmHg) or NYHA grade III or IV heart failure.
Ascites of any etiology
People with cognitive impairment or mental illness that makes it difficult to adhere to instructions.
People who do not understand Catalan or Spanish.
Factors of poor preparation: liver cirrhosis, diabetes mellitus, treatment with tricyclic antidepressants, opioids or neuroleptics, limited mobility, chronic constipation, history of colon or intestinal resection (appendectomy is not an exclusion criterion), poor preparation in previous colonoscopy Parkinson's disease, multiple sclerosis.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eva Martínez, PhD
Organizational Affiliation
Hospital Universitari Parc Taulí
Official's Role
Study Director
Facility Information:
Facility Name
Hospital Universitari Parc Taulí
City
Sabadell
State/Province
Barcelona
ZIP/Postal Code
08208
Country
Spain
12. IPD Sharing Statement
Learn more about this trial
Efficacy of Free Versus Low Residue Diet as Preparation for Screening Colonoscopy
We'll reach out to this number within 24 hrs